Carisma Therapeutics's total assets for Q1 2025 were $15.95M, a decrease of -47.62% from the previous quarter. CARM total liabilities were $52.62M for the fiscal quarter, a -9.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.